INTERNATIONAL PATENT: PRILENIA THERAPEUTICS INC. FILES APPLICATION FOR "COMBINATION OF PRIDOPIDINE AND HTT LOWERING AGENT FOR TREATING HUNTINGTON DISEASE AND SYMPTOMS THEREOF"

GENEVA, March 19 -- PRILENIA THERAPEUTICS INC. (300 Fifth Avenue, Suite 5010Waltham, Massachusetts 02451) filed a patent application (PCT/US2025/045278) for "COMBINATION OF PRIDOPIDINE AND HTT LOWERING AGENT FOR TREATING HUNTINGTON DISEASE AND SYMPTOMS THEREOF" on Sep 08, 2025. With publication no. WO/2026/055574, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HAYDEN, Michael (c/o Prilenia Therapeutics Inc.300 Fifth Avenue, Suite 5010Waltham, New York 02451), GEVA, Michal (c/o Prilenia Therapeutics Inc.300 Fifth Avenue, ...